Device Trial Radar · NCT03821142
Prospective Long-term Evaluation of the Efficacy and Safety of Calistar S for Transvaginal Pelvic Organ Prolapse Repair
Last checked: Nov 20, 2026Latest source record: Nov 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
180
Planned (sponsor's estimate)
Start
Mar 10, 2021
Primary completion
Oct 2026
Study completion Oct 2029
Sponsor
- Lead sponsor
- PromedonNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 29, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective long-term evaluation of the performance and safety of Calistar S for transvaginal pelvic organ prolapse repair in women with anterior POP with or without apical vaginal involvement
Conditions
- Pelvic Organ Prolapse
Interventions
Transvaginal mesh for anterior pelvic organ prolapse repairDevice
synthetic mesh for anterior pelvic organ prolapse with or without apical vaginal wall involvement via the vaginal route in a highly selected patient population
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Patients with Cure of pelvic organ prolapseTime frame: 24 months
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
St. Hedwig Hospital
Berlin, Germany
Evangelic Diakonie Hospital
Freiburg im Breisgau, Germany
St. Elisabeth-Hospital Leipzig
Leipzig, Germany
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.